Loading…
Effect of artificial aging on high translucent dental zirconia: simulation of early failure
Higher yttria content enhances the translucency and appearance of dental zirconia materials. Alterations in material composition also affect mechanical properties. The aim of this study was to compare the fracture load after artificial short‐term aging of monolithic, full‐contour zirconia crowns wit...
Saved in:
Published in: | European journal of oral sciences 2020-12, Vol.128 (6), p.526-534 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Higher yttria content enhances the translucency and appearance of dental zirconia materials. Alterations in material composition also affect mechanical properties. The aim of this study was to compare the fracture load after artificial short‐term aging of monolithic, full‐contour zirconia crowns with different amounts of yttria‐stabilization. Sixty crowns (thirty super high translucent crowns (5Y‐Z) and thirty high translucent crowns (3Y‐Z)) were produced to fit a model of a premolar with a shallow chamfer preparation. The crowns were cemented with self‐adhesive resin cement on composite abutments. For each zirconia type, three groups of crowns (n = 10) were allocated to: (i) cyclic loading (200 N, 1 Hz, 30,000 cycles), (ii) hydrothermal aging (3 × 20 min, 134°C 3.2 bar), or (iii) no treatment (control). Surviving crowns from the aging process were quasistatically loaded until fracture. The 3Y‐Z crowns had statistically significantly higher fracture values (3,449 N) than the 5Y‐Z crowns (1,938 N). The aging procedures did not affect load at fracture. Fractographic analysis showed that fractures started either at the crown margin or at the occlusal intaglio area. Higher yttria content leads to a reduction in material strength and damage tolerance, and this should be reflected in recommendations for clinical use. |
---|---|
ISSN: | 0909-8836 1600-0722 |
DOI: | 10.1111/eos.12739 |